+Open data
-Basic information
Entry | Database: EMDB / ID: EMD-26139 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Title | Structure of human RyR2 in the closed state. | |||||||||
Map data | Structure of human RyR2 in the closed state | |||||||||
Sample |
| |||||||||
Keywords | calcium channel / ATP / closed state / MEMBRANE PROTEIN | |||||||||
Biological species | Homo sapiens (human) | |||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.53 Å | |||||||||
Authors | Miotto MC / Marks AR | |||||||||
Funding support | United States, 1 items
| |||||||||
Citation | Journal: Sci Adv / Year: 2022 Title: Structural analyses of human ryanodine receptor type 2 channels reveal the mechanisms for sudden cardiac death and treatment. Authors: Marco C Miotto / Gunnar Weninger / Haikel Dridi / Qi Yuan / Yang Liu / Anetta Wronska / Zephan Melville / Leah Sittenfeld / Steven Reiken / Andrew R Marks / Abstract: Ryanodine receptor type 2 (RyR2) mutations have been linked to an inherited form of exercise-induced sudden cardiac death called catecholaminergic polymorphic ventricular tachycardia (CPVT). CPVT ...Ryanodine receptor type 2 (RyR2) mutations have been linked to an inherited form of exercise-induced sudden cardiac death called catecholaminergic polymorphic ventricular tachycardia (CPVT). CPVT results from stress-induced sarcoplasmic reticular Ca leak via the mutant RyR2 channels during diastole. We present atomic models of human wild-type (WT) RyR2 and the CPVT mutant RyR2-R2474S determined by cryo-electron microscopy with overall resolutions in the range of 2.6 to 3.6 Å, and reaching local resolutions of 2.25 Å, unprecedented for RyR2 channels. Under nonactivating conditions, the RyR2-R2474S channel is in a "primed" state between the closed and open states of WT RyR2, rendering it more sensitive to activation that results in stress-induced Ca leak. The Rycal drug ARM210 binds to RyR2-R2474S, reverting the primed state toward the closed state. Together, these studies provide a mechanism for CPVT and for the therapeutic actions of ARM210. | |||||||||
History |
|
-Structure visualization
Supplemental images |
---|
-Downloads & links
-EMDB archive
Map data | emd_26139.map.gz | 245.4 MB | EMDB map data format | |
---|---|---|---|---|
Header (meta data) | emd-26139-v30.xml emd-26139.xml | 13.6 KB 13.6 KB | Display Display | EMDB header |
Images | emd_26139.png | 112.6 KB | ||
Filedesc metadata | emd-26139.cif.gz | 7.7 KB | ||
Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-26139 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-26139 | HTTPS FTP |
-Validation report
Summary document | emd_26139_validation.pdf.gz | 540.3 KB | Display | EMDB validaton report |
---|---|---|---|---|
Full document | emd_26139_full_validation.pdf.gz | 539.9 KB | Display | |
Data in XML | emd_26139_validation.xml.gz | 8.2 KB | Display | |
Data in CIF | emd_26139_validation.cif.gz | 9.4 KB | Display | |
Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-26139 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-26139 | HTTPS FTP |
-Related structure data
Related structure data | 7u9qC 7u9rC 7u9tC 7u9xC 7u9zC 7ua1C 7ua3C 7ua4C 7ua5C 7ua9C C: citing same article (ref.) |
---|
-Links
EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
---|
-Map
File | Download / File: emd_26139.map.gz / Format: CCP4 / Size: 512 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | Structure of human RyR2 in the closed state | ||||||||||||||||||||||||||||||||||||
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 0.8325 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Sample components
-Entire : Complex of RyR2 with Calstabin
Entire | Name: Complex of RyR2 with Calstabin |
---|---|
Components |
|
-Supramolecule #1: Complex of RyR2 with Calstabin
Supramolecule | Name: Complex of RyR2 with Calstabin / type: complex / ID: 1 / Parent: 0 / Macromolecule list: all |
---|---|
Source (natural) | Organism: Homo sapiens (human) |
-Macromolecule #1: Ryanodine Receptor 2
Macromolecule | Name: Ryanodine Receptor 2 / type: protein_or_peptide / ID: 1 / Enantiomer: DEXTRO |
---|---|
Source (natural) | Organism: Homo sapiens (human) |
Recombinant expression | Organism: Homo sapiens (human) |
Sequence | String: MADGGEGEDE IQFLRTDDEV VLQCTATIHK EQQKLCLAAE GFGNRLCFLE STSNSKNVPP DLSICTFVL EQSLSVRALQ EMLANTVEKS EGQVDVEKWK FMMKTAQGGG HRTLLYGHAI L LRHSYSGM YLCCLSTSRS STDKLAFDVG LQEDTTGEAC WWTIHPASKQ ...String: MADGGEGEDE IQFLRTDDEV VLQCTATIHK EQQKLCLAAE GFGNRLCFLE STSNSKNVPP DLSICTFVL EQSLSVRALQ EMLANTVEKS EGQVDVEKWK FMMKTAQGGG HRTLLYGHAI L LRHSYSGM YLCCLSTSRS STDKLAFDVG LQEDTTGEAC WWTIHPASKQ RSEGEKVRVG DD LILVSVS SERYLHLSYG NGSLHVDAAF QQTLWSVAPI SSGSEAAQGY LIGGDVLRLL HGH MDECLT VPSGEHGEEQ RRTVHYEGGA VSVHARSLWR LETLRVAWSG SHIRWGQPFR LRHV TTGKY LSLMEDKNLL LMDKEKADVK STAFTFRSSK EKLDVGVRKE VDGMGTSEIK YGDSV CYIQ HVDTGLWLTY QSVDVKSVRM GSIQRKAIMH HEGHMDDGIS LSRSQHEESR TARVIR STV FLFNRFIRGL DALSKKAKAS TVDLPIESVS LSLQDLIGYF HPPDEHLEHE DKQNRLR AL KNRQNLFQEE GMINLVLECI DRLHVYSSAA HFADVAGREA GESWKSILNS LYELLAAL I RGNRKNCAQF SGSLDWLISR LERLEASSGI LEVLHCVLVE SPEALNIIKE GHIKSIISL LDKHGRNHKV LDVLCSLCVC HGVAVRSNQH LICDNLLPGR DLLLQTRLVN HVSSMRPNIF LGVSEGSAQ YKKWYYELMV DHTEPFVTAE ATHLRVGWAS TEGYSPYPGG GEEWGGNGVG D DLFSYGFD GLHLWSGCIA RTVSSPNQHL LRTDDVISCC LDLSAPSISF RINGQPVQGM FE NFNIDGL FFPVVSFSAG IKVRFLLGGR HGEFKFLPPP GYAPCYEAVL PKEKLKVEHS REY KQERTY TRDLLGPTVS LTQAAFTPIP VDTSQIVLPP HLERIREKLA ENIHELWVMN KIEL GWQYG PVRDDNKRQH PCLVEFSKLP EQERNYNLQM SLETLKTLLA LGCHVGISDE HAEDK VKKM KLPKNYQLTS GYKPAPMDLS FIKLTPSQEA MVDKLAENAH NVWARDRIRQ GWTYGI QQD VKNRRNPRLV PYTLLDDRTK KSNKDSLREA VRTLLGYGYN LEAPDQDHAA RAEVCSG TG ERFRIFRAEK TYAVKAGRWY FEFETVTAGD MRVGWSRPGC QPDQELGSDE RAFAFDGF K AQRWHQGNEH YGRSWQAGDV VGCMVDMNEH TMMFTLNGEI LLDDSGSELA FKDFDVGDG FIPVCSLGVA QVGRMNFGKD VSTLKYFTIC GLQEGYEPFA VNTNRDITMW LSKRLPQFLQ VPSNHEHIE VTRIDGTIDS SPCLKVTQKS FGSQNSNTDI MFYRLSMPIE CAEVFSKTVA G GLPGAGLF GPKNDLEDYD ADSDFEVLMK TAHGHLVPDR VDKDKEATKP EFNNHKDYAQ EK PSRLKQR FLLRRTKPDY STSHSARLTE DVLADDRDDY DFLMQTSTYY YSVRIFPGQE PAN VWVGWI TSDFHQYDTG FDLDRVRTVT VTLGDEKGKV HESIKRSNCY MVCAGESMSP GQGR NNNGL EIGCVVDAAS GLLTFIANGK ELSTYYQVEP STKLFPAVFA QATSPNVFQF ELGRI KNVM PLSAGLFKSE HKNPVPQCPP RLHVQFLSHV LWSRMPNQFL KVDVSRISER QGWLVQ CLD PLQFMSLHIP EENRSVDILE LTEQEELLKF HYHTLRLYSA VCALGNHRVA HALCSHV DE PQLLYAIENK YMPGLLRAGY YDLLIDIHLS SYATARLMMN NEYIVPMTEE TKSITLFP D ENKKHGLPGI GLSTSLRPRM QFSSPSFVSI SNECYQYSPE FPLDILKSKT IQMLTEAVK EGSLHARDPV GGTTEFLFVP LIKLFYTLLI MGIFHNEDLK HILQLIEPSV FKEAATPEEE SDTLEKELS VDDAKLQGAG EEEAKGGKRP KEGLLQMKLP EPVKLQMCLL LQYLCDCQVR H RIEAIVAF SDDFVAKLQD NQRFRYNEVM QALNMSAALT ARKTKEFRSP PQEQINMLLN FK DDKSECP CPEEIRDQLL DFHEDLMTHC GIELDEDGSL DGNSDLTIRG RLLSLVEKVT YLK KKQAEK PVESDSKKSS TLQQLISETM VRWAQESVIE DPELVRAMFV LLHRQYDGIG GLVR ALPKT YTINGVSVED TINLLASLGQ IRSLLSVRMG KEEEKLMIRG LGDIMNNKVF YQHPN LMRA LGMHETVMEV MVNVLGGGES KEITFPKMVA NCCRFLCYFC RISRQNQKAM FDHLSY LLE NSSVGLASPA MRGSTPLDVA AASVMDNNEL ALALREPDLE KVVRYLAGCG LQSCQML VS KGYPDIGWNP VEGERYLDFL RFAVFCNGES VEENANVVVR LLIRRPECFG PALRGEGG N GLLAAMEEAI KIAEDPSRDG PSPNSGSSKT LDTEEEEDDT IHMGNAIMTF YSALIDLLG RCAPEMHLIH AGKGEAIRIR SILRSLIPLG DLVGVISIAF QMPTIAKDGN VVEPDMSAGF CPDHKAAMV LFLDRVYGIE VQDFLLHLLE VGFLPDLRAA ASLDTAALSA TDMALALNRY L CTAVLPLL TRCAPLFAGT EHHASLIDSL LHTVYRLSKG CSLTKAQRDS IEVCLLSICG QL RPSMMQH LLRRLVFDVP LLNEHAKMPL KLLTNHYERC WKYYCLPGGW GNFGAASEEE LHL SRKLFW GIFDALSQKK YEQELFKLAL PCLSAVAGAL PPDYMESNYV SMMEKQSSMD SEGN FNPQP VDTSNITIPE KLEYFINKYA EHSHDKWSMD KLANGWIYGE IYSDSSKVQP LMKPY KLLS EKEKEIYRWP IKESLKTMLA WGWRIERTRE GDSMALYNRT RRISQTSQVS VDAAHG YSP RAIDMSNVTL SRDLHAMAEM MAENYHNIWA KKKKMELESK GGGNHPLLVP YDTLTAK EK AKDREKAQDI LKFLQINGYA VSRGFKDLEL DTPSIEKRFA YSFLQQLIRY VDEAHQYI L EFDGGSRGKG EHFPYEQEIK FFAKVVLPLI DQYFKNHRLY FLSAASRPLC SGGHASNKE KEMVTSLFCK LGVLVRHRIS LFGNDATSIV NCLHILGQTL DARTVMKTGL ESVKSALRAF LDNAAEDLE KTMENLKQGQ FTHTRNQPKG VTQIINYTTV ALLPMLSSLF EHIGQHQFGE D LILEDVQV SCYRILTSLY ALGTSKSIYV ERQRSALGEC LAAFAGAFPV AFLETHLDKH NI YSIYNTK SSRERAALSL PTNVEDVCPN IPSLEKLMEE IVELAESGIR YTQMPHVMEV ILP MLCSYM SRWWEHGPEN NPERAEMCCT ALNSEHMNTL LGNILKIIYN NLGIDEGAWM KRLA VFSQP IINKVKPQLL KTHFLPLMEK LKKKAATVVS EEDHLKAEAR GDMSEAELLI LDEFT TLAR DLYAFYPLLI RFVDYNRAKW LKEPNPEAEE LFRMVAEVFI YWSKSHNFKR EEQNFV VQN EINNMSFLIT DTKSKMSKAA VSDQERKKMK RKGDRYSMQT SLIVAALKRL LPIGLNI CA PGDQELIALA KNRFSLKDTE DEVRDIIRSN IHLQGKLEDP AIRWQMALYK DLPNRTDD T SDPEKTVERV LDIANVLFHL EQKSKRVGRR HYCLVEHPQR SKKAVWHKLL SKQRKRAVV ACFRMAPLYN LPRHRAVNLF LQGYEKSWIE TEEHYFEDKL IEDLAKPGAE PPEEDEGTKR VDPLHQLIL LFSRTALTEK CKLEEDFLYM AYADIMAKSC HDEEDDDGEE EVKSFEEKEM E KQKLLYQQ ARLHDRGAAE MVLQTISASK GETGPMVAAT LKLGIAILNG GNSTVQQKML DY LKEKKDV GFFQSLAGLM QSCSVLDLNA FERQNKAEGL GMVTEEGSGE KVLQDDEFTC DLF RFLQLL CEGHNSDFQN YLRTQTGNNT TVNIIISTVD YLLRVQESIS DFYWYYSGKD VIDE QGQRN FSKAIQVAKQ VFNTLTEYIQ GPCTGNQQSL AHSRLWDAVV GFLHVFAHMQ MKLSQ DSSQ IELLKELMDL QKDMVVMLLS MLEGNVVNGT IGKQMVDMLV ESSNNVEMIL KFFDMF LKL KDLTSSDTFK EYDPDGKGVI SKRDFHKAME SHKHYTQSET EFLLSCAETD ENETLDY EE FVKRFHEPAK DIGFNVAVLL TNLSEHMPND TRLQTFLELA ESVLNYFQPF LGRIEIMG S AKRIERVYFE ISESSRTQWE KPQVKESKRQ FIFDVVNEGG EKEKMELFVN FCEDTIFEM QLAAQISESD LNERSANKEE SEKERPEEQG PRMAFFSILT VRSALFALRY NILTLMRMLS LKSLKKQMK KVKKMTVKDM VTAFFSSYWS IFMTLLHFVA SVFRGFFRII CSLLLGGSLV E GAKKIKVA ELLANMPDPT QDEVRGDGEE GERKPLEAAL PSEDLTDLKE LTEESDLLSD IF GLDLKRE GGQYKLIPHN PNAGLSDLMS NPVPMPEVQE KFQEQKAKEE EKEEKEETKS EPE KAEGED GEKEEKAKED KGKQKLRQLH THRYGEPEVP ESAFWKKIIA YQQKLLNYFA RNFY NMRML ALFVAFAINF ILLFYKVSTS SVVEGKELPT RSSSENAKVT SLDSSSHRII AVHYV LEES SGYMEPTLRI LAILHTVISF FCIIGYYCLK VPLVIFKREK EVARKLEFDG LYITEQ PSE DDIKGQWDRL VINTQSFPNN YWDKFVKRKV MDKYGEFYGR DRISELLGMD KAALDFS DA REKKKPKKDS SLSAVLNSID VKYQMWKLGV VFTDNSFLYL AWYMTMSVLG HYNNFFFA A HLLDIAMGFK TLRTILSSVT HNGKQLVLTV GLLAVVVYLY TVVAFNFFRK FYNKSEDGD TPDMKCDDML TCYMFHMYVG VRAGGGIGDE IEDPAGDEYE IYRIIFDITF FFFVIVILLA IIQGLIIDA FGELRDQQEQ VKEDMETKCF ICGIGNDYFD TVPHGFETHT LQEHNLANYL F FLMYLINK DETEHTGQES YVWKMYQERC WEFFPAGDCF RKQYEDQLN |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
Processing | single particle reconstruction |
Aggregation state | particle |
-Sample preparation
Buffer | pH: 7.4 |
---|---|
Grid | Model: UltrAuFoil R0.6/1 |
Vitrification | Cryogen name: ETHANE |
-Electron microscopy
Microscope | FEI TITAN KRIOS |
---|---|
Image recording | Film or detector model: GATAN K3 (6k x 4k) / Average electron dose: 58.0 e/Å2 |
Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.0 µm / Nominal defocus min: 1.0 µm |
Experimental equipment | Model: Titan Krios / Image courtesy: FEI Company |
-Image processing
Startup model | Type of model: NONE |
---|---|
Final reconstruction | Resolution.type: BY AUTHOR / Resolution: 3.53 Å / Resolution method: FSC 0.143 CUT-OFF / Number images used: 34247 |
Initial angle assignment | Type: NOT APPLICABLE |
Final angle assignment | Type: NOT APPLICABLE |